Using single atom substitution strategy for constructing a novel Se-substituted hemicyanine dye with hydroxyl group as an ideal activatable photosensitizer dye scaffold
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. The fast-growing field of photo-driven theranostics based on aggregation-induced emission10.1039/D1CS01138C ↗
2. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer10.1021/acs.accounts.0c00606 ↗
3. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
4. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
5. Mitochondria-targeted nanotheranostic: harnessing single-laser-activated dual phototherapeutic processing for hypoxic tumor treatment10.1016/j.matt.2021.05.022 ↗
6. Activity-based smart AIEgens for detection, bioimaging, and therapeutics: recent progress and outlook10.1002/agt2.51 ↗
7. Activation of apoptosis by rationally constructing NIR amphiphilic AIEgens: surmounting the shackle of mitochondrial membrane potential for amplified tumor ablation10.1039/D1SC02227J ↗
8. In situ transformable nanoplatforms with supramolecular cross-linking triggered complementary function for enhanced cancer photodynamic therapy10.1002/adma.202209944 ↗
9. Mitochondria-targeted smart AIEgens: imaging and therapeutics10.1016/j.ccr.2022.214818 ↗
10. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
11. Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors10.1021/jacs.8b08658 ↗
12. An activatable photosensitizer targeted to γ-glutamyltranspeptidase10.1002/anie.201704793 ↗
13. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
14. Universal scaffold for an activatable photosensitizer with completely inhibited photosensitivity10.1002/anie.201907510 ↗
15. Activatable photosensitizers for imaging and therapy10.1021/cr900236h ↗
16. Heavy atom-free, mitochondria-targeted, and activatable photosensitizers for photodynamic therapy with real-time in-situ therapeutic monitoring10.1002/anie.202201815 ↗
17. Activatable photosensitizer for targeted ablation of lacZ-positive cells with single-cell resolution10.1021/acscentsci.9b00678 ↗
18. Specific activation of photosensitizer with extrinsic enzyme for precisive photodynamic therapy10.1021/jacs.2c04017 ↗
19. Enzyme-responsive double-locked photodynamic molecular beacon for targeted photodynamic anticancer therapy10.1021/jacs.2c13732 ↗
20. A leucine aminopeptidase activatable photosensitizer for cancer cell selective photodynamic therapy action10.1016/j.dyepig.2021.109735 ↗
21. A pH-responsive organic photosensitizer specifically activated by cancer lysosomes10.1016/j.dyepig.2018.04.008 ↗
22. BODIPY dyes in photodynamic therapy10.1039/C2CS35216H ↗
23. Photosensitization and controlled photosensitization with BODIPY dyes10.1016/j.ccr.2017.09.029 ↗
24. The concept and examples of type-III photosensitizers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
25. Activatable near-infrared versatile fluorescent and chemiluminescent dyes based on the dicyanomethylene-4H-pyran scaffold: from design to imaging and theranostics10.1002/anie.202311764 ↗
26. Photoactivatable senolysis with single-cell resolution delays aging10.1038/s43587-023-00360-x ↗
27. Hemicyanine-based near-infrared activatable probes for imaging and diagnosis of diseases10.1002/anie.202107877 ↗
28. An activatable polymeric nanoprobe for fluorescence and photoacoustic imaging of tumor-associated neutrophils in cancer immunotherapy10.1002/anie.202203184 ↗
29. Activity-based NIR fluorescent probes based on the versatile hemicyanine scaffold: design strategy, biomedical applications, and outlook10.1039/D1CS00307K ↗
30. Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy10.1039/C9SC03355F ↗
31. Single-atom engineering of hemicyanine and its amphiphilic derivative for optimized near infrared phototheranostics10.1039/D2SC05982G ↗
32. A ratiometric near-infrared fluorescent probe for hydrazine and its in vivo applications10.1021/ol401838p ↗
33. A near-infrared ratiometric fluorescent probe for rapid and highly sensitive imaging of endogenous hydrogen sulfide in living cells10.1039/c3sc50369k ↗
34. A unique approach to development of near-infrared fluorescent sensors for in vivo imaging10.1021/ja305802v ↗
35. On the use of 1,3-diphenylisobenzofuran (DPBF). Reactions with carbon and oxygen centered radicals in model and natural systems10.1163/156856793X00181 ↗
36. Uniting dual-modal MRI/chemiluminescence nanotheranostics: spatially and sensitively self-reporting photodynamic therapy in oral cancer10.1002/adfm.202303240 ↗
37. The role of structural hydrophobicity on cationic amphiphilic aggregation-induced emission photosensitizer-bacterial interaction and photodynamic efficiency10.1021/acsnano.3c04266 ↗
38. Molecular structural evolution of near-infrared cationic aggregation-induced emission luminogens: preclinical antimicrobial pathogens activities and tissues regeneration10.31635/ccschem.021.202101206 ↗
39. Construction of rhodamine-based AIE photosensitizer hydrogel with clinical potential for selective ablation of drug-resistant gram-positive bacteria in vivo10.1002/adhm.202200837 ↗